DYOR vs RNAC
Comparison between Insight Digital Partners II (DYOR, Company) and Cartesian Therapeutics Inc (RNAC, Company).
DYOR is from the Financial Services sector, while RNAC is from the Healthcare sector.
DYOR vs RNAC - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
DYOR vs RNAC - Historical Returns
Returns include dividend reinvestment.
DYOR vs RNAC - Annual Returns (2016 - 2026)
Returns include dividend reinvestment.
| Year | DYOR | RNAC |
|---|---|---|
| 2026 | +1.61% | +17.16% |
| 2025 | -0.50% | -57.41% |
| 2024 | N/A | -8.88% |
| 2023 | N/A | -40.05% |
| 2022 | N/A | -65.86% |
| 2021 | N/A | +9.03% |
| 2020 | N/A | +31.74% |
| 2019 | N/A | -17.93% |
| 2018 | N/A | -74.02% |
| 2017 | N/A | -43.23% |
| 2016 | N/A | +22.50% |
DYOR vs RNAC Drawdown Comparison
The maximum drawdown for DYOR was -0.60%, occurring on Nov 26, 2025. Recovery took 50 trading sessions.
The maximum drawdown for RNAC was -99.26%, occurring on Jun 5, 2026. This drawdown has not yet recovered.
The current DYOR drawdown is -0.30%. The current RNAC drawdown is -99.00%.
| Rank | DYOR | RNAC |
|---|---|---|
| #1 | -0.60% Nov 18, 2025 - Feb 2, 2026 | -99.26% Nov 25, 2016 - Jun 5, 2026 |
| #2 | -0.59% Jun 5, 2026 - Jun 30, 2026 | -24.79% Jul 13, 2016 - Sep 21, 2016 |
| #3 | -0.40% Feb 2, 2026 - Apr 20, 2026 | -16.26% Sep 26, 2016 - Oct 18, 2016 |
| #4 | -0.30% May 15, 2026 - May 28, 2026 | -7.33% Nov 11, 2016 - Nov 22, 2016 |
| #5 | -0.20% May 4, 2026 - May 11, 2026 | -5.47% Oct 19, 2016 - Oct 31, 2016 |
| #6 | -0.20% May 11, 2026 - May 15, 2026 | -2.75% Nov 8, 2016 - Nov 10, 2016 |
| #7 | -0.10% May 28, 2026 - Jun 5, 2026 | -2.49% Sep 21, 2016 - Sep 23, 2016 |
| #8 | -0.05% Apr 30, 2026 - May 4, 2026 | -1.35% Nov 3, 2016 - Nov 7, 2016 |
| #9 | N/A | -0.36% Jul 8, 2016 - Jul 13, 2016 |
| #10 | N/A | -0.29% Jun 23, 2016 - Jul 8, 2016 |
Correlation
Correlation between DYOR and RNAC is 0.42 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks